Biomerica, Inc.
Biomerica, Inc. (BMRA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bmra · pe ratio · data through May 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Biomerica, Inc. (BMRA) measures how much investors pay for each dollar of the company's trailing earnings. BMRA's current PE ratio of N/A is calculated by dividing its stock price of $2.07 by its TTM earnings per share of -$1.39.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-05-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%80.0x
MedianQ3 · 75%152.5x
Max
At N/A, BMRA's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Biomerica, Inc.You BMRA | $6M | N/A | — | -$1.39 |
 Alzamend Neuro, Inc. ALZN | $4M | N/A | — | -$11.34 |
 Creative Medical Technology Holdings, Inc. CELZ | $6M | N/A | — | -$2.52 |
 HeartSciences Inc. HSCS | $4M | N/A | — | -$9.34 |
 Inspira Technologies Oxy B.H.N. Ltd. IINN | $45M | N/A | — | -$0.45 |
 Lifeward Ltd. LFWD | $11M | N/A | — | -$1.72 |
 Innovative Eyewear, Inc. LUCY | $4M | N/A | — | -$1.90 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-05-31Latest FY2025 | — | $-2.16 | — | |
2024-05-31 FY2024 | — | $-0.36 | — | |
2023-05-31 FY2023 | — | $-0.50 | — | |
2022-05-31 FY2022 | — | $-0.36 | — | |
2021-05-31 FY2021 | — | $-0.62 | — | |
2020-05-31 FY2020 | — | $-0.23 | — | |
2019-05-31 FY2019 | — | $-0.26 | — | |
2018-05-31 FY2018 | — | $-0.17 | — | |
2017-05-31 FY2017 | — | $-0.11 | — | |
2016-05-31 FY2016 | — | $-0.20 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Biomerica, Inc. (BMRA) measures how much investors pay for each dollar of the company's trailing earnings. BMRA's current PE ratio of N/A is calculated by dividing its stock price of $2.07 by its TTM earnings per share of -$1.39.
Frequently asked questions
BMRA pe ratio · 6 questionsBMRA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.07 and TTM EPS of -$1.39. Data sourced from Financial Modeling Prep via BMRA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biomerica, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09